| Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study L Beaugerie, N Brousse, AM Bouvier, JF Colombel, M Lémann, J Cosnes, ... The Lancet 374 (9701), 1617-1625, 2009 | 1217 | 2009 |
| ESPEN guidelines on artificial enteral nutrition--percutaneous endoscopic gastrostomy (PEG) C Löser, G Aschl, X Hébuterne, EM Mathus-Vliegen, M Muscaritoli, Y Niv, ... Clin Nutr 24 (5), 848-61, 2005 | 916 | 2005 |
| Prevalence of malnutrition and current use of nutrition support in patients with cancer X Hébuterne, E Lemarié, M Michallet, CB de Montreuil, SM Schneider, ... Journal of Parenteral and Enteral Nutrition 38 (2), 196-204, 2014 | 866 | 2014 |
| Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial JF Colombel, R Panaccione, P Bossuyt, M Lukas, F Baert, T Vaňásek, ... The Lancet 390 (10114), 2779-2789, 2017 | 819 | 2017 |
| ESPEN guideline: Clinical nutrition in inflammatory bowel disease A Forbes, J Escher, X Hébuterne, S Kłęk, Z Krznaric, S Schneider, ... Clinical Nutrition 36 (2), 321-347, 2017 | 703 | 2017 |
| A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease P Brest, P Lapaquette, M Souidi, K Lebrigand, A Cesaro, ... Nature genetics 43 (3), 242-245, 2011 | 660 | 2011 |
| ESPEN guidelines on enteral nutrition: gastroenterology H Lochs, C Dejong, F Hammarqvist, X Hébuterne, M Leon-Sanz, T Schütz, ... Clinical nutrition 25 (2), 260-274, 2006 | 586 | 2006 |
| ESPEN Guidelines on Parenteral Nutrition: home parenteral nutrition (HPN) in adult patients M Staun, L Pironi, F Bozzetti, J Baxter, A Forbes, F Joly, P Jeppesen, ... Clinical nutrition 28 (4), 467-479, 2009 | 573 | 2009 |
| Malnutrition is an independent factor associated with nosocomial infections SM Schneider, P Veyres, X Pivot, AM Soummer, P Jambou, J Filippi, ... British journal of nutrition 92 (1), 105-111, 2004 | 477 | 2004 |
| Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn’s disease J Panés, D García-Olmo, G Van Assche, JF Colombel, W Reinisch, ... Gastroenterology 154 (5), 1334-1342. e4, 2018 | 458 | 2018 |
| Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo … S Vermeire, S Schreiber, R Petryka, T Kuehbacher, X Hebuterne, ... The Lancet 389 (10066), 266-275, 2017 | 444 | 2017 |
| Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease P Desreumaux, A Foussat, M Allez, L Beaugerie, X Hébuterne, Y Bouhnik, ... Gastroenterology 143 (5), 1207-1217. e2, 2012 | 420 | 2012 |
| Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation M Vivinus-Nébot, G Frin-Mathy, H Bzioueche, R Dainese, G Bernard, ... Gut 63 (5), 744-752, 2014 | 405 | 2014 |
| Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials BG Feagan, WJ Sandborn, U Mittmann, S Bar-Meir, G D’Haens, ... Jama 299 (14), 1690-1697, 2008 | 348 | 2008 |
| Nutritional deficiencies in patients with Crohn's disease in remission J Filippi, R Al-Jaouni, JB Wiroth, X Hébuterne, SM Schneider Inflammatory bowel diseases 12 (3), 185-191, 2006 | 330 | 2006 |
| ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease SC Bischoff, J Escher, X Hébuterne, S Kłęk, Z Krznaric, S Schneider, ... Clinical Nutrition 39 (3), 632-653, 2020 | 324 | 2020 |
| Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s disease after ileocolonic resection M Regueiro, BG Feagan, B Zou, J Johanns, MA Blank, M Chevrier, ... Gastroenterology 150 (7), 1568-1578, 2016 | 317 | 2016 |
| Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation L Pironi, F Joly, A Forbes, V Colomb, M Lyszkowska, J Baxter, S Gabe, ... Gut 60 (1), 17-25, 2011 | 279 | 2011 |
| Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome T Piche, MC Saint-Paul, R Dainese, E Marine-Barjoan, A Iannelli, ... Gut 57 (4), 468-473, 2008 | 271 | 2008 |
| Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials S Danese, S Vermeire, W Zhou, AL Pangan, J Siffledeen, S Greenbloom, ... The lancet 399 (10341), 2113-2128, 2022 | 264 | 2022 |
Stéphane M. SchneiderPU-PH, Université Côte d'Azur, CHU de Nice在 univ-cotedazur.fr 的電子郵件地址已通過驗證
